2014 ACR/ARHP Annual Meeting Archives - Page 202 of 202

Abstract Number: 2404

RA Patients with Inadequate Response to Oral MTX Maintain Satisfactory Disease Control and Durable Long-Term Response When Switched to SC MTX Monotherapy
Abstract Number: 2290

Race and Other Risk Markers of Uveitis in a Prospective Cohort of Children with Juvenile Idiopathic Arthritis
Abstract Number: 900

Race and Sex Specific Incidence Rates and Predictors of Total Knee Arthroplasty: Data from the Osteoarthritis Initiative, 7 Years Follow up
Abstract Number: 1024

Racial Differences in Biochemical Knee Cartilage Composition Between African American and Caucasian American Women with MR-Based T2 Relaxation Time Measurements – Data from the Osteoarthritis Initiative
Abstract Number: 1935

Racial Disparities in Attitude Towards Treatment in Young Women
Abstract Number: 972

Racial, Gender and Geographic Differences in Systemic Lupus Erythematous and Lupus Nephritis Mortality Rates in the Unites States, 1968-2010
Abstract Number: 1387

Radiographic Progression Differs Between Trajectory Clusters Defined By DAS28 Scores in Early Rheumatoid Arthritis
Abstract Number: 595

Radiographic Sacroiliitis Progression in an Early Axial Spondyloarthritis Cohort
Abstract Number: 2138

Radiological Outcomes after Two Years of Remission Steered Treatment in Early Arthritis Patients
Abstract Number: 2262

Raloxifene for Osteoporosis in Postmenopausal Women with Rheumatic Diseases
Abstract Number: L11

Raman Spectroscopy: Point of Service Diagnosis Is Sensitive and Specific-a Tool for Improving Accuracy and Reducing Future Hospital Admission
Abstract Number: 2860

Randomised Comparison of the Effectiveness of a Non-Pharmacological Multidisciplinary Face-to-Face Group-Based Treatment Program Vs. a Telephone-Delivered Treatment Program on Daily Function in Patients with Generalized Osteoarthritis
Abstract Number: 1843

Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis
Abstract Number: 977

Randomized Clinical Trial of a Patient and Provider Intervention for Managing Osteoarthritis in Veterans
Abstract Number: 891

Randomized Clinical Trial of Group Vs. Individual Physical Therapy for Knee Osteoarthritis
Abstract Number: 2859

Randomized Controlled Trial of Postoperative Care Navigation in Total Knee Arthroplasty Patients: Does One Size Fit All?
Abstract Number: 920

Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis
Abstract Number: L19

Randomized Trial of Stopping TNF-Inhibitors in Rheumatoid Arthritis Patients with Stable Low Disease Activity in the Netherlands
Abstract Number: 238

RANKL and OPG Gene Polymorphisms: Association with Vertebral Fractures and Bone Mineral Density in Premenopausal Systemic Lupus Erythematosus
Abstract Number: 2722

Rapamycin Corrects GATA-3 Deficiency in Lupus Treg
Abstract Number: 1486

Rapid Onset of Clinical Benefit Is Associated with a Reduction in Validated Biomarkers of Disease in Patients with Rheumatoid Arthritis Treated with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRÃ¡
Abstract Number: 1656

Rate of Histological Transformation to Higher Grade Nephritis in Class II Mesangial Proliferative Lupus Glomerulonephritis
Abstract Number: 901

Rate of Serum Uric Acid (SUA) Assessment in Gout Patients Treated with Urate-Lowering Therapy: Treating to Target?
Abstract Number: 1051

Rates of Renal Remission with Immunosuppressives in Lupus Nephritis: A Systematic Review and Network Meta-Analysis
Abstract Number: 2010

Reaching out to Physical Therapists: Results of a Survey on Physical Therapists Preferences for Learning about Evidence-Based Community Programs
Abstract Number: 484

Reactivation of Hepatitis B Virus in Patients with Rheumatoid Arthritis after Anti-TNF Therapy
Abstract Number: 2121

Real-World Cost Comparison of Urate Lowering Therapies in Patients with Gout and Moderate to Severe Chronic Kidney Disease
Abstract Number: 517

Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients in Canada: Interim Results
Abstract Number: 102

Real-World Utilization, Patient Characteristics and Persistency of Certolizumab Pegol Vs Other Anti-TNFs for the Treatment of Rheumatoid Arthritis in the United Kingdom
Abstract Number: 956

Real-World Validation of the Minimal Disease Activity Index in Psoriatic Arthritis: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
Abstract Number: 2516

Reasons and Risk Factor for Discontinuation of Biologic Agents in Rheumatoid Arthritis Patients
Abstract Number: 104

Reasons for Leaving an Academic Career in Research Among Rheumatologists in the United States
Abstract Number: 2385

Reasons for Non-Vaccination in Rheumatoid Arthritis and Spondyloarthritis Patients
Abstract Number: 2572

Recognition of Spondyloarthritis By General Practitioners in Daily Practice and the Effect of Education on This; A Study with Standardized Patients
Abstract Number: 1235

Recovery of Renal Function after Corticosteroid Therapy for IgG4-Related Kidney Disease
Abstract Number: 1417

Red Cell Distribution Width: A Measure for Cardiovascular Risk in Rheumatoid Arthritis Patients?
Abstract Number: 2210

Redefining Dermatomyositis: Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis from Overlap Myositis with Dermatomyositis Features
Abstract Number: 2342

Redox Regulation of a New Autoimmune Mouse Model, Glucose-6-Phosphate Isomerase Peptide Induced Arthritis in Mice
Abstract Number: 725

Reduced Diffusing Capacity of Carbon Monoxide Is Independently Associated with Worse Subclinical Left Ventricular Function on Speckle-Tracking Echocardiography in Systemic Sclerosis
Abstract Number: 241

Reduced Estimated Glomerular Filtration Rate Was Improved after Cessation of NSAID and Switching to Tramadol Hydrochloride/Acetaminophen Tablets (Ultracet^TM) in Patients with Chronic Musculoskeletal Pain
Abstract Number: 1016

Reduced Expression of Circadian Rhythm Genes in Human Osteoarthritis Cartilage: NR1D1 Suppression Alters Chondrocyte Response to IL-1β Stimulation
Abstract Number: 2753

Reduced Heart Rate Variability in Patients with Behcet’s Disease
Abstract Number: 344

Reduced Macrophages in the Synovium Contribute to the Effective Treatment of Spontanneous Arthritis Observeded in Human TNF-Transgenic Mice
Abstract Number: 2810

Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts
Abstract Number: 940

Reducing Therapy in Rheumatoid Arthritis Patients in Ongoing Remission
Abstract Number: 963

Reduction in Proteinuria and Normalization of C4 Complement Levels Predict Response to Treatment of Lupus Nephritis with Low-Dose Pulse Cyclophosphamide and Abatacept
Abstract Number: 2705

Reduction of Cerebral and Corpus Callosum Volume in Systemic Sclerosis. a Volumetric Magnetic Resonance Imaging Study
Abstract Number: 2246

Reduction of Knee Osteoarthritis Symptoms in a Cohort of Bariatric Surgery Patients
Abstract Number: 2728

Reduction of MAIT Cell Frequency Associated with Reduced Cell Proliferation and Enhanced Cell Death in Systemic Lupus Erythematosus
Abstract Number: 2221

Reduction of Ovarian Reserve in Adult Patients with Dermatomyositis
Abstract Number: 1009

Regeneration of Articular Cartilage in Situ with Bone Marrow-Derived Mesenchymal Stem Cells
Abstract Number: 2412

Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice
Abstract Number: 1675

Regional Implantation of Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients with Systemic Sclerosis
Abstract Number: 37

Regulation of Osteoclast and T Cell Differentiation By DC-STAMP and TRAF3
Abstract Number: 1128

Regulation of PIWIL4 By Histone Modifications in Rheumatoid Arthritis
Abstract Number: 32

Regulation of Senescence and Inflammatory Mediators By N- and C-Terminal Parathyroid Hormone-Related Protein in Osteoarthritic Human Osteoblasts
Abstract Number: 1942

Regulation of the Responses of Human B Cell Subsets to Innate Immune Signals By Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22
Abstract Number: 324

Regulation of TNF-α-Mediated Activation of Rheumatoid Synovial Fibroblasts By Transcription Factor Snail
Abstract Number: 835

Relapsing Polychondritis Can be Characterized By 3 Different Clinical Phenotypes: Analysis of a Series of 142 Patients
Abstract Number: 2387

Relation Between Disease Activity Indices and Their Individual Components and Radiographic Progression in Rheumatoid Arthritis: A Systematic Literature Review
Abstract Number: 1539

Relation Between Number of Previous Anti TNF Agents and Clinical Response in Rheumatoid Arthritis Patients Treated with Rituximab
Abstract Number: 973

Relation of Pelvic Drop during Walking to Risk of Incident Medial Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 212

Relation of Shoe Stability to Risk of Knee Cartilage Damage: The Multicenter Osteoarthritis Study
Abstract Number: 1647

Relationship Between Apom/S1P Levels and Atherosclerosis in Women with Systemic Lupus Erythematosus
Abstract Number: 2488

Relationship Between Different Clinical Measurements and Patient-Reported Outcomes
Abstract Number: 508

Relationship Between NK Cell Count and Important Safety Events in Rheumatoid Arthritis Patients Treated with Tofacitinib
Abstract Number: 1570

Relationship Between Psoriatic Arthritis Severity, Duration, and Comorbidities
Abstract Number: 414

Relationship Between Range of Motion of Joints in Upper Limbs and Physical Function in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
Abstract Number: 112

Relationship Between Rheumatology Physician Supply and Travel Distances to Rheumatologists for Medicare Beneficiaries in the United States
Abstract Number: 2696

Relationship Between Soluble sCD23 and B Cell Activation Factor in Patients with Systemic Lupus Erythematosus before and after Rituximab
Abstract Number: 2149

Relationship Between the Magnitude of Bone Formation in the Anterior Vertebral Corners, As Assessed through 18F-Fluoride Uptake, and Lumbar Spine Bone Mineral Density in Patients with Ankylosing Spondylitis
Abstract Number: 1280

Relationship of Buckling and Knee Injury to Pain Exacerbation in Knee Osteoarthritis: A Web-Based Case-Crossover Stud
Abstract Number: 2894

Relationship of Dermal Advanced Glycation End Products and Hand OA
Abstract Number: 2626

Relationship of Socio-Demographic and Disease Factors with Loss-to-Follow-up and Appointment Noncompliance in Indigent Patients with Systemic Lupus Erythematosus
Abstract Number: 1291

Relationships Between Inflammation, Disease Severity and Synovial Fluid Calcium Crystals Detected By Scanning Electronic Microscopy in Early Osteoarthritis
Abstract Number: 2183

Release of Enzymatically Active Peptidyl Arginine Deiminases (PADs) By Neutrophils Allows Generation of Citrullinated Extracellular Autoantigens in the Synovial Fluid of Patients with Rheumatoid Arthritis
Abstract Number: 2701

Relevance of the 6-Minute Walking Test in Assessing the Severity and Outcome of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis, without Extensive Interstitial Lung Disease
Abstract Number: 549

Reliability and Construct Validity of the Psoriasis Symptom Inventory in Subjects with Psoriatic Arthritis
Abstract Number: 2335

Reliability and Validity of the Arthritis Helplessness Index in Systemic Sclerosis
Abstract Number: 2715

Reliability and Validity of the Duruöz Hand Index in an Argentinian Population with Scleroderma
Abstract Number: 2614

Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments
Abstract Number: 737

Reliability of Nailfold Capillary Density Measurement As a Possible Outcome Measure for Systemic Sclerosis-Related Microangiopathy
Abstract Number: 352

Remaining Pain in Spite of Suppressed Inflammation in Early Rheumatoid Arthritis – Long-Term Strongly Increased Risk for Widespread Pain and Fatigue
Abstract Number: L15

Remission Induction By Etanercept in Enthesitis Related Arthritis JIA-Patients (juvenile undifferentiated Spondylarthropathy)
Abstract Number: 474

Renacer Study: Assessment of 12-Month Efficacy and Safety of 168 Certolizumabpegol Rheumatoid Arthritis Treated Patients from a Multicenter Retrospective National Study in Spain
Abstract Number: 2549

Renal Involvement in Primary Sjögren’s Syndrome: A Multicenter French Study of 95 Biopsy Proven Cases
Abstract Number: 1671

Renal Relapses Are Common in Lupus Nephritis
Abstract Number: 1658

Renal Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Novel Risk Factors and Clinical Outcomes
Abstract Number: 2086

Replication of PTPRC As Genetic Biomarker of Response to TNF Inhibitors in Patients with Rheumatoid Arthritis
Abstract Number: 1188

Reproducibility of Magnetic Resonance Imaging Diffusion Weighted Imaging in Axial Spondyloarthritis Patients and Healthy Subjects
Abstract Number: 1992

Resident’s Guide to Rheumatology Mobile Application: An International Needs Assessment
Abstract Number: 2975

Residual Large Joint Synovitis By Power Doppler Ultrasonography Is Associated with Higher Disease Activity and Significant Impact of Disease in Multi-Ethnic Asian Patients with Established Rheumatoid Arthritis
Abstract Number: 1588

Resistance Training in Patients with Psoriatic Arthritis Improves Function, Disease Activity and Quality of Life
Abstract Number: 105

Resource Use and Health Related Quality of Life Burden of Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
Abstract Number: 2038

Respiratory Cause Mortality Was Significantly Predicted By Incident Rheumatoid Arthritis (RA) and Higher Pre-RA Levels (0.50+ SD) of Soluble Interleukin-2 Receptor Alpha (sIL-2Rá): Results of a 21-Year Community-Based Cohort Survival Analysis
Abstract Number: 1482

Response of Patient Reported Symptoms of Stiffness and Pain during the Day from Adding Low-Dose Delayed-Release (DR) Prednisone to Stable DMARD Therapy over 12 Weeks in Patients with Moderate Rheumatoid Arthritis (RA)
Abstract Number: 931

Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients
Abstract Number: 676

Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
Abstract Number: 897

Resting State Functional Connectivity Differs Between Chronic Fatigue Syndrome Patients and Healthy Controls
Abstract Number: 2857

Restricting Back Pain Is Strongly Associated with Disability in Community-Living Older Persons over the Course of 13 Years
Abstract Number: 1277

Retinal Arteriolar Narrowing and Incidence of Knee Replacement for Osteoarthritis: A Prospective Cohort Study
Abstract Number: 1237

Retroperitoneal Fibrosis and IgG4 Disease: Response to Immunosuppressive Therapy – a Single Centre Retrospective Study
Abstract Number: 281

Retrospective Review of Immobilization Vs. Immediate Resumption of Activity in Patients with Oligoarticular Juvenile Idiopathic Arthritis and Corticosteroid Knee Injections
Abstract Number: 1576

Reversal of Damage in Psoriatic Arthritis
Abstract Number: 187

Revision Arthroplasty in Rheumatoid and Osteoarthritis: Does Methotrexate Decrease Radiographic Lucency in RA Patients?
Abstract Number: 2187

Revisiting RS3PE after Twenty Five Years: A Systematic Review of 250 Cases
Abstract Number: 1352

Rheumatoid Arthritis (RA) Disease Activity Assessment and Population Management Processes Used By Clinician Rheumatologists
Abstract Number: 1889

Rheumatoid Arthritis (RA)-Associated Risk Allele LBH Alters the Function of a Differentially Methylated LBH Enhancer
Abstract Number: 2136

Rheumatoid Arthritis Erosion Detection and Measurement in Longitudinal Datasets Using High-Resolution Peripheral Quantitative Computed Tomography
Abstract Number: 995

Rheumatoid Arthritis Patients Have Alterations in Inherently Autoreactive 9G4+ B-Cell Subpopulations in Peripheral Blood
Abstract Number: 2425

Rheumatoid Arthritis Stable Follow up Visits – 3 Month Versus 6 Month Intervals
Abstract Number: 432

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Risk Factors for Disease Progression
Abstract Number: 846

Rheumatoid Arthritis, Anti-Tumor Necrosis Factor Therapy, and Risk of Squamous Cell and Basal Cell Skin Cancer- a Nationwide Population Based Prospective Cohort Study from Sweden
Abstract Number: 1904

Rheumatoid Factor Isotype Testing to Identify Individuals in the Preclinical Period of Rheumatoid Arthritis
Abstract Number: 447

Rheumatoid Factor Isotypes in Relation to Antibodies Against Citrullinated Peptides in Individuals before Onset of Rheumatoid Arthritis
Abstract Number: 1560

Rheumatoid Factor Status Is a Predictor of Osteoporosis in Patients with Psoriatic Arthritis
Abstract Number: 1054

Rheumatoid Factor, Not ACPA, Is Associated with Disease Activity in Rheumatoid Arthritis
Abstract Number: 1361

Rheumatologists’ Attitudes on Cardiovascular Risk and Lipid Screening in Patients with Rheumatoid Arthritis at an Academic Medical Center
Abstract Number: 103

Rheumatology e-Consult Services: a Rheumatology Workforce Management Model
Abstract Number: 1985

Rheumatology Learning Management System
Abstract Number: 2883

Rheumatology-Specific Milestones for a Musculoskeletal Radiology Curriculum
Abstract Number: 781

Rho Kinase (ROCK) Activity in Aortitis: Comparison of Giant Cell Arteritis (GCA), Takayasu Arteritis (TA) and Isolated Aortitis (IA)
Abstract Number: 350

Rho-Associated Protein Kinase (ROCK) Activity Is Elevated in Rheumatoid Arthritis (RA) Patients and May be Responsive to RA Therapies
Abstract Number: 740

Right Ventricular Diastolic Impairment Is Common in Systemic Sclerosis and Is a Marker of Several Organ-Target Damage of the Disease
Abstract Number: 475

Risk Analysis of a First Adverse Event and Recurrent Infections during Biological Therapy in Chronic Inflammatory Arthritis
Abstract Number: 862

Risk Factors for Changes in Subclinical Atherosclerosis As Measured By Carotid Intima Media Thickness (IMT) and Plaque over 5 Years in Women with Systemic Lupus Erythematosus (SLE)
Abstract Number: 223

Risk Factors for Clinical Vertebral Fractures in Japanese Men and Women with Rheumatoid Arthritis: Results from a Large Prospective Observational Cohort Study
Abstract Number: 166

Risk Factors for Gout Attack Recurrence during Urate-Lowering Allopurinol Treatment
Abstract Number: 206

Risk Factors for Increased Extrusion of the Meniscus Body in Subjects Free of Radiographic Knee Osteoarthritis: 6-Year MRI Data from the Osteoarthritis Initiative
Abstract Number: 2990

Risk Factors for Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus Patients: A Single Center Study
Abstract Number: 236

Risk Factors for Prevalent and Progressive Bone Deficits Among Adult Men and Women with Cystic Fibrosis
Abstract Number: 809

Risk Factors for Severe Ischemic Complications in Takayasu Arteritis: A French Multicenter Retrospective Cohort of 182 Patients
Abstract Number: 2266

Risk Factors for Treatment Failure in Osteoporotic Patients with Rheumatoid Arthritis
Abstract Number: 230

Risk Factors That Predict Poor Bone Health in Those Aged over 75 Years – a Cross Sectional Study
Abstract Number: 2154

Risk for Developing Adult T-Cell Leukemia in Patients with Human T Lymphotropic Virus Type-I Carrier Receiving Immunosuppressive Therapy
Abstract Number: 823

Risk of Active Tuberculosis in Patients with Arthritis Receiving TNF-α Inhibitors: A Look Beyond the Baseline Tuberculosis Screening Protocol
Abstract Number: 1848

Risk of Cancer in Patients with Severe Psoriatic Arthritis Requiring Tumour-Necrosis Factor Alpha Inhibition
Abstract Number: 2628

Risk of Cancer Is Not Increased in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
Abstract Number: 2642

Risk of Cardiovascular Events in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
Abstract Number: 2545

Risk of Cervical Root and Incisal Caries in Patients with Sjogren’s Syndrome
Abstract Number: 970

Risk of Developing Antiphospholipid Syndrome Following Infection: A Systematic Review and Meta-Analysis of Observational Studies
Abstract Number: 483

Risk of HBV Reactivation in Rheumatoid Arthritis Patients Undergoing Treatment with Newer Biological Dmards, Tocilizumab and Abatacept: A Single-Center Real Life Experience
Abstract Number: 1075

Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus on Immunosuppressive Drugs
Abstract Number: 57

Risk of Hospitalized Infection in a Psoriasis/Psoriatic Arthritis Cohort
Abstract Number: 2665

Risk of Hydrocephalus and/or Macrocephaly in Children Born to Mothers with SLE
Abstract Number: 1910

Risk of Hypersensitiviy Among Medicare Patients with Rheumatoid Arthritis Who Were Taking Biologics
Abstract Number: 518

Risk of Infection Associated with Subsequent Biologic Use Following Rituximab—Results from a National RA Patient Registry
Abstract Number: 1082

Risk of Intra Cranial Hemorrhage among Patients with Anti-Phospho-Lipid-Antibody (aPL) syndrome vs Systemic Lupus Erythematosus (SLE) in Stroke Population: A Nationwide Analysis
Abstract Number: 726

Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-Analysis
Abstract Number: 1849

Risk of Malignancy Among Medicare Psoriasis/Psoriasis Arthritis Patients
Abstract Number: 1546

Risk of Non Melanoma Skin Cancer Among Medicare Psoriasis/Psoriasis Arthritis Patients
Abstract Number: 1589

Risk of Opportunistic Infection and Herpes Zoster Infection in a Psoriasis/Psoriatic Arthritis Cohort
Abstract Number: 1839

Risk of Recurrent Non-Melanoma Skin Cancer with Methotrexate and Anti-TNF Use in Rheumatoid Arthritis
Abstract Number: 1400

Risk of Venous Thromboembolic Events in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
Abstract Number: 2531

Risk of Venous Thromboembolism in Patients with Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
Abstract Number: 1524

Rituximab Done! What’s Next in RA?
Abstract Number: 2804

Rituximab in IgG4-Related Disease: A Large Single-Center Experience
Abstract Number: 1419

Rituximab Use in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease and Other Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Experience
Abstract Number: 1778

Rituximab Versus Azathioprine for ANCA-Associated Vasculitis Maintenance Therapy: Impact in Health-Related Quality of Life
Abstract Number: 14

Rivaroxaban Use in Patients with Antiphospholipid Syndrome Patients and Previous Poor Anticoagulation Control with Vitamin K Antagonists
Abstract Number: 1814

RNA-Containing Immune Complexes Shift Human Neutrophils from Phagocytosing Cells to Efficient Releasers of Oxidized DNA in a Process Requiring Crosstalk Between Toll-like Receptors and Fc Gamma Receptor IIa
Abstract Number: 772

RNA-Seq and Mir-Seq Analysis of SSc Skin Across Intrinsic Gene Expression Subsets Shows Differential Expression of Non-Coding RNAs Regulating SSc Gene Expression
Abstract Number: 75

Robust Identification of Anti-TNF Non-Responders in RA from Blood
Abstract Number: 340

Role of Beta-Catenin Signaling to Control Dendritic Cell Function in Collagen-Induced Arthritis
Abstract Number: 1829

Role of Fluorinated Steroids in Preventing the Progression of Anti-SSA/Ro Associated Isolated Congenital Heart Block to Disease Beyond the Conduction System
Abstract Number: 1012

Role of High Glucose Environment on Chondrocyte Activation and Characterization of Diabetic Osteoarthritic Cartilage: Toward Pathophysiological Delineation of Diabetes Mellitus-Related Osteoarthritis
Abstract Number: 1808

Role of HLA-B*5801 Genetic Testing and a Safety Programme When Initiating Allopurinol Therapy for Chronic Gout Management: A Cost-Effectiveness Analysis
Abstract Number: 1643

Role of Inflammasome Activation in Systemic Lupus Erthematosus: Are Innate Immune Cells Activated?
Abstract Number: 287

Role of Joint Status in Decreased Accelerometer-Assessed Daily Physical Activity in Juvenile Idiopathic Arthritis
Abstract Number: 1978

Role of Monocytes Subsets in the Pathology of Rheumatoid Arthritis: Involvement in Endothelial Dysfunction and Proinflammatory Profile
Abstract Number: 2173

Role of Natural Killer Cells and Gamma Delta T Cells in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis
Abstract Number: 1134

Role of NOD2 Pathway in Sarcoidosis Cases with Characteristics of Blau Syndrome
Abstract Number: 2352

RORγt Expressing Foxp3⁺ Regulatory T Cells Regulates the Development of Autoimmune Arthritis in Mice
Abstract Number: 489

Rosuvastatin Improves Arterial Stiffness in Patients with Inflammatory Joint Diseases
Abstract Number: 1913

Rosuvastatin Induced Carotid Plaque Regression in Patients with Inflammatory Joint Diseases
Abstract Number: 2568

Routine Assessment of Patient Index Data (RAPID3) Provides Similar Information Compared to Ankylosing Spondylitis Specific Indices: Analyses of the DESIR French Cohort